23 ML hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection
RxNorm concept 2693458, clinical drug (scd). Prescribable name: ocrelizumab-ocsq 920 MG / hyaluronidase-ocsq 23,000 UNT in 23 ML Injection.
- RxCUI
- 2693458
- Term type
- Clinical drug (SCD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2693458 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
ocrelizumab-hyaluronidase-ocsq 920 MG / 23,000 UNT per 23 ML Injection; ocrelizumab-ocsq 920 MG / hyaluronidase-ocsq 23,000 UNT per 23 ML Injection
Related concepts
- ocrelizumab-ocsq 40 MG/ML (SCDC, consists of)
- hyaluronidase-ocsq 1000 UNT/ML (SCDC, consists of)
- Injection (DF, has dose form)
- 23 ML hyaluronidase-ocsq 1000 UNT/ML / ocrelizumab-ocsq 40 MG/ML Injection [Ocrevus Zunovo] (SBD, has tradename)
Linked data
NDCs
RxNorm links no NDCs to this concept.
Use it
Look up 2693458 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2693458 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2693458. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.